A Clinical Study To Assess The Safety And Effectiveness Of The OMNI® Surgical System

Completed

Conditions studied: Glaucoma, Open-Angle

In brief

The purpose of this study is to evaluate the long-term safety and effectiveness of the OMNI® Surgical System in subjects who were treated under protocol #06213

Key facts

Study ID

NCT05044793

Run by

Sight Sciences, Inc.

People needed

70

Starts

2021-09-01

Expected to finish

2023-08-21

Last updated by the study team

2025-01-22

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participated in, received treatment, and completed Protocol #06213

You may not qualify if…

• Systemic disease that, in the opinion of the Investigator, would put the subject's health at risk and/or prevent completion of required study visits
• Ocular pathology which, in the Investigator's judgment, would either place the subject at increased risk of complications, contraindicate washout, place the subject at risk of significant vision loss during the study period (e.g., wet age macular degeneration (AMD), corneal edema, Fuch's dystrophy, active intraocular infection or inflammation within 30 days prior to Screening Visit, etc.), or interfere with compliance to elements of the study protocol (e.g., returning to Investigator's office for follow-up visits)

Where it is running

• Grene Vision Group — Wichita, Kansas, United States
• Oklahoma Eye Surgeons — Oklahoma City, Oklahoma, United States
• Northern Ophthalmics — Jenkintown, Pennsylvania, United States
• El Paso Eye Surgeons — El Paso, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.